Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 367

1.

Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes.

Porrini E, Ruggenenti P, Mogensen CE, Barlovic DP, Praga M, Cruzado JM, Hojs R, Abbate M, de Vries AP; ERA-EDTA diabesity working group.

Lancet Diabetes Endocrinol. 2015 May;3(5):382-91. doi: 10.1016/S2213-8587(15)00094-7.

PMID:
25943757
2.

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, Arima H, Monaghan H, Joshi R, Colagiuri S, Cooper ME, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Lisheng L, Mancia G, Marre M, Matthews DR, Mogensen CE, Perkovic V, Poulter N, Rodgers A, Williams B, MacMahon S, Patel A, Woodward M; ADVANCE-ON Collaborative Group.

N Engl J Med. 2014 Oct 9;371(15):1392-406. doi: 10.1056/NEJMoa1407963. Epub 2014 Sep 19.

3.

The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.

Schernthaner G, Mogensen CE, Schernthaner GH.

Diab Vasc Dis Res. 2014 Sep;11(5):306-23. doi: 10.1177/1479164114542802. Review.

4.

Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease.

de Vries AP, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, D'Agati VD, Lamb HJ, Pongrac Barlovic D, Hojs R, Abbate M, Rodriquez R, Mogensen CE, Porrini E; ERA-EDTA Working Group Diabesity.

Lancet Diabetes Endocrinol. 2014 May;2(5):417-26. doi: 10.1016/S2213-8587(14)70065-8. Review.

PMID:
24795255
5.

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.

Molitch ME, Adler AI, Flyvbjerg A, Nelson RG, So WY, Wanner C, Kasiske BL, Wheeler DC, de Zeeuw D, Mogensen CE.

Kidney Int. 2015 Jan;87(1):20-30. doi: 10.1038/ki.2014.128. Epub 2014 Apr 30.

6.

Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial.

Arjona Ferreira JC, Corry D, Mogensen CE, Sloan L, Xu L, Golm GT, Gonzalez EJ, Davies MJ, Kaufman KD, Goldstein BJ.

Am J Kidney Dis. 2013 Apr;61(4):579-87. doi: 10.1053/j.ajkd.2012.11.043. Epub 2013 Jan 24. Erratum in: Am J Kidney Dis. 2013 Oct;62(4):847.

PMID:
23352379
7.

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.

Perkovic V, Heerspink HL, Chalmers J, Woodward M, Jun M, Li Q, MacMahon S, Cooper ME, Hamet P, Marre M, Mogensen CE, Poulter N, Mancia G, Cass A, Patel A, Zoungas S; ADVANCE Collaborative Group.

Kidney Int. 2013 Mar;83(3):517-23. doi: 10.1038/ki.2012.401. Epub 2013 Jan 9.

8.

Prediction of kidney-related outcomes in patients with type 2 diabetes.

Jardine MJ, Hata J, Woodward M, Perkovic V, Ninomiya T, Arima H, Zoungas S, Cass A, Patel A, Marre M, Mancia G, Mogensen CE, Poulter N, Chalmers J; ADVANCE Collaborative Group.

Am J Kidney Dis. 2012 Nov;60(5):770-8. doi: 10.1053/j.ajkd.2012.04.025. Epub 2012 Jun 12.

PMID:
22694950
9.

Predictors of mortality of patients newly diagnosed with clinical type 2 diabetes: a 5-year follow up study.

de Fine Olivarius N, Siersma V, Nielsen AB, Hansen LJ, Rosenvinge L, Mogensen CE.

BMC Endocr Disord. 2010 Aug 10;10:14. doi: 10.1186/1472-6823-10-14.

10.

Mistakes, misunderstandings and controversies in diabetes: A review and personal account.

Mogensen CE.

J Diabetes Investig. 2010 Jun 1;1(3):97-100. doi: 10.1111/j.2040-1124.2010.00012.x. Review.

11.

Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease.

Heerspink HJ, Ninomiya T, Perkovic V, Woodward M, Zoungas S, Cass A, Cooper M, Grobbee DE, Mancia G, Mogensen CE, Neal B, Chalmers J; ADVANCE Collaborative Group.

Eur Heart J. 2010 Dec;31(23):2888-96. doi: 10.1093/eurheartj/ehq139. Epub 2010 May 25.

PMID:
20501479
12.

Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.

Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, Cass A, Cooper M, Grobbee D, Hamet P, Harrap S, Liu L, Mancia G, Mogensen CE, Poulter N, Rodgers A, Williams B, MacMahon S, Chalmers J; ADVANCE Collaborative Group.

J Hypertens. 2010 Jun;28(6):1141-9.

PMID:
20486273
13.

[Microalbuminuria].

Olsen MH, Ibsen H, Mogensen CE.

Ugeskr Laeger. 2009 Jun 15;171(25):2097-100. Danish.

PMID:
19671389
14.

Microalbuminuria and short-term prognosis in patients undergoing cardiac surgery.

Mikkelsen MM, Andersen NH, Christensen TD, Hansen TK, Eiskjaer H, Mogensen CE, Hjortdal VE, Johnsen SP.

Interact Cardiovasc Thorac Surg. 2009 Sep;9(3):484-90. doi: 10.1510/icvts.2009.203836. Epub 2009 Jun 23.

PMID:
19549646
15.

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J; ADVANCE Collaborative Group.

J Am Soc Nephrol. 2009 Aug;20(8):1813-21. doi: 10.1681/ASN.2008121270. Epub 2009 May 14.

16.

Increased ambulatory arterial stiffness index and pulse pressure in microalbuminuric patients with type 1 diabetes.

Laugesen E, Hansen KW, Knudsen ST, Erlandsen M, Ebbehøj E, Mogensen CE, Poulsen PL.

Am J Hypertens. 2009 May;22(5):513-9. doi: 10.1038/ajh.2009.27. Epub 2009 Feb 26.

PMID:
19247265
17.

Lowering blood pressure reduces renal events in type 2 diabetes.

de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Glasziou P, Grobbee DE, MacMahon S, Chalmers J; ADVANCE Collaborative Group.

J Am Soc Nephrol. 2009 Apr;20(4):883-92. doi: 10.1681/ASN.2008070667. Epub 2009 Feb 18.

18.

Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients.

Knudsen ST, Laugesen E, Hansen KW, Bek T, Mogensen CE, Poulsen PL.

Diabetologia. 2009 Apr;52(4):698-704. doi: 10.1007/s00125-009-1262-6. Epub 2009 Jan 29.

PMID:
19183937
19.

The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.

Rydén L, Waeber B, Ruilope LM, Mancia G, Volpe M, Holzgreve H, Mogensen CE, Laurent S.

Blood Press. 2008;17(5-6):250-9. doi: 10.1080/08037050802513387. Review.

PMID:
19012063
20.

Twelve shifting paradigms in diabetic renal disease and hypertension.

Mogensen CE.

Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S2-9. doi: 10.1016/j.diabres.2008.09.029. Epub 2008 Oct 23.

PMID:
18947897
21.

Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study.

Sadikot SM, Mogensen CE.

Diabetes Res Clin Pract. 2008 Dec;82(3):391-5. doi: 10.1016/j.diabres.2008.09.004. Epub 2008 Oct 21.

PMID:
18945509
22.

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.

Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE.

J Nephrol. 2008 Jul-Aug;21(4):566-9.

PMID:
18651547
23.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.

24.

[Measurement of postprandial blood glucose level and the necessary difference between the valuable and invaluable].

Møller N, Poulsen PL, Nielsen S, Mogensen CE.

Ugeskr Laeger. 2008 Apr 21;170(17):1483. Danish. No abstract available.

PMID:
18476317
25.

Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.

Knudsen ST, Andersen NH, Poulsen SH, Eiskjaer H, Hansen KW, Helleberg K, Poulsen PL, Mogensen CE.

Am J Hypertens. 2008 Feb;21(2):172-6. doi: 10.1038/ajh.2007.2. Epub 2008 Jan 10.

PMID:
18188164
26.

[Diabetic angiopathy].

Mogensen CE.

Ugeskr Laeger. 2007 Aug 27;169(35):2893. Danish. No abstract available.

PMID:
17878001
27.

Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria.

Nellemann B, Gormsen LC, Dollerup J, Schmitz O, Mogensen CE, Rasmussen LM, Nielsen S.

Diabetes Care. 2007 Dec;30(12):3122-4. Epub 2007 Sep 5. No abstract available.

PMID:
17804683
28.

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.

Lancet. 2007 Sep 8;370(9590):829-40.

PMID:
17765963
29.

Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.

Knudsen ST, Jeppesen P, Frederiksen CA, Andersen NH, Bek T, Ingerslev J, Mogensen CE, Poulsen PL.

Diabet Med. 2007 Aug;24(8):911-5. Epub 2007 Jun 8.

PMID:
17559428
30.

Response of retinal arteriole diameter to increased blood pressure during acute hyperglycaemia.

Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Schmitz O, Bek T.

Acta Ophthalmol Scand. 2007 May;85(3):280-6.

31.

Endothelial perturbation: a link between non-dipping and retinopathy in type 2 diabetes?

Knudsen ST, Jeppesen P, Frederiksen CA, Andersen NH, Bek T, Ingerslev J, Mogensen CE, Poulsen PL.

J Am Soc Hypertens. 2007 May-Jun;1(3):208-15. doi: 10.1016/j.jash.2007.02.006.

PMID:
20409852
32.

Plasma concentrations of osteoprotegerin during normo- and hyperglycaemic clamping.

Knudsen ST, Jeppesen P, Poulsen PL, Andersen NH, Bek T, Schmitz O, Mogensen CE, Rasmussen LM.

Scand J Clin Lab Invest. 2007;67(2):135-42.

PMID:
17365993
33.

Ambulatory pulse pressure and progression of albuminuria in type 2 diabetes: evidence provided, new questions emerge.

Knudsen ST, Andersen NH, Mogensen CE.

Hypertension. 2006 Aug;48(2):207-8. Epub 2006 Jul 3. No abstract available.

PMID:
16818799
34.

The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy.

Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T.

Graefes Arch Clin Exp Ophthalmol. 2006 Oct;244(10):1255-61. Epub 2006 Mar 15.

PMID:
16538448
35.

Effects of blood pressure lowering and metabolic control on systolic left ventricular function in Type II diabetes mellitus.

Andersen NH, Poulsen SH, Poulsen PL, Knudsen ST, Helleberg K, Hansen KW, Dinesen DS, Eiskjaer H, Flyvbjerg A, Mogensen CE.

Clin Sci (Lond). 2006 Jul;111(1):53-9.

PMID:
16512787
36.

Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study.

Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Snapinn SM, Wan Y, Lyle PA.

Diabetes Care. 2006 Mar;29(3):595-600.

PMID:
16505512
37.

Urinary creatinine concentration is inversely related to glycaemic control and the presence of some diabetic complications in patients with newly diagnosed Type 2 diabetes.

de Fine Olivarius N, Andreasen AH, Vestbo E, Holstein-Rathlou NH, Jørgensen LG, Mogensen CE.

J Diabetes Complications. 2006 Jan-Feb;20(1):45-50.

PMID:
16389167
38.

Myocardial injury with biomarker elevation in diabetic ketoacidosis.

Moller N, Foss AC, Gravholt CH, Mortensen UM, Poulsen SH, Mogensen CE.

J Diabetes Complications. 2005 Nov-Dec;19(6):361-3.

PMID:
16260354
39.

[Vascular impact of anti-hypertensive treatment and renal protection].

Mogensen CE.

Curr Med Res Opin. 2005;21 Suppl 5:S23-8. French.

PMID:
16197649
40.

Left ventricular dysfunction in hypertensive patients with Type 2 diabetes mellitus.

Andersen NH, Poulsen SH, Poulsen PL, Knudsen ST, Helleberg K, Hansen KW, Berg TJ, Flyvbjerg A, Mogensen CE.

Diabet Med. 2005 Sep;22(9):1218-25.

PMID:
16108852
42.

[Is there any documentation for Lyrica in the treatment of painful diabetic neuropathy?].

Persson F, Mogensen CE, Mandrup-Poulsen T.

Ugeskr Laeger. 2005 Apr 18;167(16):1768-9; author reply 1769-70. Danish. No abstract available.

PMID:
15898613
43.

[HbA1 and type 2 diabetes--what is optimal?].

Møller N, Poulsen L, Schmitz OE, Parving HH, Mogensen CE.

Ugeskr Laeger. 2005 Apr 4;167(14):1542-3; author reply 1544. Danish. No abstract available.

PMID:
15887757
44.

Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.

Zhang Z, Shahinfar S, Keane WF, Ramjit D, Dickson TZ, Gleim GW, Mogensen CE, de Zeeuw D, Brenner BM, Snapinn SM.

J Am Soc Nephrol. 2005 Jun;16(6):1775-80. Epub 2005 May 4.

45.
46.
47.

Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study.

Andersen NH, Poulsen PL, Knudsen ST, Poulsen SH, Eiskjaer H, Hansen KW, Helleberg K, Mogensen CE.

Diabetes Care. 2005 Feb;28(2):273-7.

PMID:
15677778
48.

NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus.

Andersen NH, Poulsen SH, Knudsen ST, Heickendorff L, Mogensen CE.

Diabet Med. 2005 Feb;22(2):188-95.

PMID:
15660737
49.

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.

Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y.

Hypertension. 2005 Feb;45(2):198-202. Epub 2005 Jan 17.

PMID:
15655123
50.

Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: insights from the RENAAL study.

Parving HH, Mogensen CE, Thomas MC, Brenner BM, Cooper ME.

QJM. 2005 Feb;98(2):119-26. Epub 2005 Jan 17.

PMID:
15655096

Supplemental Content

Loading ...
Support Center